Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC, Wang J, Liu N, Tatonetti N, Bourgeois S, Takahashi H, Bradford Y, Burkley BM, Desnick RJ, Halperin JL, Khalifa SI, Langaee TY, Lubitz SA, Nutescu EA, Oetjens M, Shahin MH, Patel SR, Sagreiya H, Tector M, Weck KE, Rieder MJ, Scott SA, Wu AH, Burmester JK, Wadelius M, Deloukas P, Wagner MJ, Mushiroda T, Kubo M, Roden DM, Cox NJ, Altman RB, Klein TE, Nakamura Y, Johnson JA
Lancet. 2013 382 (9894): 790-6

PMID: 23755828 · PMCID: PMC3759580 · DOI:10.1016/S0140-6736(13)60681-9

MeSH Terms (14)

African Americans Alleles Anticoagulants Aryl Hydrocarbon Hydroxylases Cytochrome P-450 CYP2C9 Female Genome-Wide Association Study Genotype Humans Male Mixed Function Oxygenases Polymorphism, Single Nucleotide Vitamin K Epoxide Reductases Warfarin

Connections (3)

This publication is referenced by other Labnodes entities:

Links